Development of phenylpropanoid sucrose esters (PSEs) as lead drug candidates for alpha glucosidase inhibition
This research work focuses on the development of Phenylpropanoid Sucrose Esters (PSEs) as lead antidiabetic Alpha Glucosidase Inhibitors (AGIs) with the ultimate aim of eliminating the side effects associated with the current commercial drugs (Acarbose, Miglitol and Voglibose). Structure Activity Re...
Saved in:
Main Author: | Devaraj, Surabhi |
---|---|
Other Authors: | Zaher Judeh |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/69613 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Cinnamoyl sucrose esters as alpha glucosidase inhibitors for the treatment of diabetes
by: Devaraj, Surabhi, et al.
Published: (2021) -
Development of phenylpropanoid sucrose esters as antidiabetic lead compounds
by: Ong, Li Lin
Published: (2019) -
Targeted synthesis of 3,3'-, 3,4'- and 3,6'-phenylpropanoid sucrose esters
by: Wong, Kathy Pooi Wen, et al.
Published: (2022) -
Synthesis and anticancer activity of phenylpropanoid sucrose esters
by: Parthasarathi Panda
Published: (2015) -
An orthogonal approach for the precise synthesis of phenylpropanoid sucrose esters
by: Ong, Li Lin, et al.
Published: (2022)